A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CAELYX IN COMBINATION WITH CARBOPLATIN IN PATIENTS WITH OVARIAN CANCER RECURRENT WITHIN SIX TO TWELVE MONTHS AFTER INITIAL CARBOPLATIN AND PACLITAXEL CHEMOTHERAPY (P03625):